Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis-Reference-Cited by-同舟云学术

Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis

Published:2014-10-14 Issue:4 Volume:69 Page:436-443
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Hsu J. C.¹,Tang D. H.²,Lu C. Y.³

Affiliation:

1. School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences; College of Medicine, National Cheng Kung University; Tainan City Taiwan

2. Department of Pharmaceutical Sciences; The University of Arizona College of Pharmacy; Tucson AZ USA

3. Department of Population Medicine; Harvard Medical School and Harvard Pilgrim Health Care Institute; Boston MA USA

Funder

National Science Council Taiwan

Publisher

Hindawi Limited

Subject

General Medicine

Reference39 articles.

1. Multi-criteria clinical decision support: a primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare;Dolan;Patient,2010

2. Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectives;Leong;Pharmacoepidemiol Drug Saf,2013

3. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake;NIH Consensus Conference;JAMA,1994

4. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study;Feldman;J Urol,1994

5. Importance of and satisfaction with sex among men and women worldwide: results of the global better sex survey;Mulhall;J Sex Med,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the Interplay of Emotional and Physiological Factors in Sexual Well-being of Men in Ekiti State, Nigeria.;Sierra Leone Journal of Medicine;2024-09-11

2. Pain Treatment Evaluation in COVID-19 Patients with Hesitant Fuzzy Linguistic Multicriteria Decision-Making;Journal of Healthcare Engineering;2021-02-01

3. Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature;Therapeutic Advances in Drug Safety;2020-01

4. Evaluating treatment modalities in chronic pain treatment by the multi-criteria decision making procedure;BMC Medical Informatics and Decision Making;2019-10-15

5. Risk Benefit Assessment of foods: Key findings from an international workshop;Food Research International;2019-02